• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

The Weekly Roundup: March 11-15


ICYMI, this week we had news about AAD sessions and late-breaking research, the establishment of the very first annual National Dermatologist Day, benzene updates, and more.

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Richard Gallo, MD, PhD: Updates on Understanding the Pathophysiology of Acne

Gallo presented pearls on the pathophysiology of acne and how newer studies have changed acne treatment methodologies at AAD 2024.

Navigating Delusional Infestations in Dermatology

Jenny Murase, MD, said the average dermatologist manages 2-3 patients with delusional infestations every 5 years. Learn what to expect and how to manage it with empathy.

Peter Lio, MD, FAAD: Minimizing Pain and Addressing Systemic Malignancy With Alternative Therapies

Lio spoke with Dermatology Times to discuss his sessions at AAD 2024, including addressing systemic malignancies with alternative or adjunctive therapies and the importance of minimizing pain in dermatology procedures.

Sharing Innovations in Psoriasis Biologics and Uplifting Women in Dermatology

Mona Shahriari, MD, presented real-world data on the efficacy of IL-23 inhibitors for psoriasis, as well as shared her advice from the Bristol Myers Squibb Women’s Connection Forum.

Late-Breaking Phase 2b Data Showed Efficacy of Injectable Polidocanol for Submental Fat Reduction

The injectable polidocanol exhibited high efficacy, quicker onset of benefit, reduced downtime, and fewer side effects lasting longer than 30 days.

Jill Waibel, MD, FAAD: Innovations in Laser Modalities for the Treatment of Scars

Waibel shared pearls in laser therapy and other scar treatment modalities in her talks at the American Academy of Dermatology Annual Meeting.

Science Behind OTC Products to Enhance Care for Atopic Dermatitis, Acne, and Sun Protection

Menes Kizoulis shared key highlights from the research conducted alongside leading dermatologists, like Alan Irvine, MD, DSc, and Patricia Farris, MD, MS.

Addressing Antibiotic Stewardship and Acne Guidelines at AAD

Naiem Issa, MD, PhD, emphasized the importance of increased awareness regarding antibiotic stewardship among dermatologists, as well as the recently updated acne guidelines.

Maternal Hidradenitis Suppurativa Linked to Increased Risk of Childhood Morbidity

Presented at the American Academy of Dermatology Annual Meeting, the poster was the winner of the second place poster award.

American Academy of Dermatology Upholds Diversity Policies in Face of Anti-DEI Proposal

A vote during the annual meeting will keep DEI initiatives in place and members are awaiting news on what those initiatives will look like.

Updates on Benzene in Benzoyl Peroxide Products at AAD

Christopher Bunick, MD, PhD, presented updates and new data on the recent news of benzene found in benzoyl peroxide products.

2024 AAD Annual Meeting Recap: Day 4

Catch up on coverage from the fourth day of the 2024 American Academy of Dermatology Annual Meeting.

Research Presented at AAD Explores Relationship Between Vitiligo and Skin Tone Bias in Google Searches

Several posters presented at the American Academy of Dermatology Annual Meeting explored the topic of skin tone bias related to vitiligo in Google and internet search platforms.

Lisa Swanson, MD, FAAD: Clinical Pearls and Updates for Pediatric Dermatology

Swanson shared updates and a look ahead and what's in store for the field of pediatric dermatology.

When Comparing JAKs to Immunomodulators, Analysis Revealed Equal or Lower Incidence Rates For Major Adverse Events

Presented at the American Academy of Dermatology Annual Meeting, the poster was the winner of the third place poster award.

Late-Breaking Data: Povorcitinib Significantly Improves Itch and Lesions in Prurigo Nodularis

Shawn Kwatra, MD, shares positive updates on phase 2 oral povorcitinib for prurigo nodularis at AAD 2024.

Cheri Frey, MD, FAAD: Exploring Cosmeceutical Ingredients and Their Role in Skin Health

Frey discussed the role of various cosmeceuticals and ingredients in benefitting the skin health of patients, as well as insights into pairing OTC products with Rx.

Advocating for Increased Representation of Women in Dermatology

The Bristol Myers Squibb-hosted event brought together a panel of leading women in dermatology to discuss the challenges they’ve faced and how women can support each other.

Red, Itchy, And AD Until Proven Otherwise

Raj Chovatiya, MD, PhD, delves into the conditions that could be red, itchy, and not atopic dermatitis. He explains the importance of knowing characteristics for various inflammatory conditions.

Serving Those Who Serve Our Communities: Melanoma in Veterans and Firefighters

Rebecca Hartman, MD, MPH, FAAD, and Christine Kannler, MD, FAAD, took a deep dive into considerations and pearls to treat patients who have been exposed to extreme heat and chemicals in the line of duty.

Environmental Factors Affecting Pigmentation And The Skin Exposome

Arianne Shadi Kourosh, MD, MPH, FAAD, shared pearls on environmental factors that can impact skin aging and pigmentation including visible light, IR radiation, location, and pollution.

Catching Up With Karan Lal, DO, MS FAAD

In between sessions, Lal shared his favorite pearls from AAD, a recent challenging pediatric case in his practice, the significance of LinkedIn, and more.

What’s New in Hair Loss Therapies and Exosomes?

Ronda Farah, MD, FAAD, reviews top hair loss pearls from her 5 sessions at AAD 2024.

How Can Patients Benefit From New Device, TruFacial?

Founder Dina El-Sherif, MBA, gave an in-depth overview of the at-home facial rejuvenation device and its 3-step process at AAD 2024.

2024 AAD Annual Meeting Recap: Day 5

Catch up on coverage from the fifth and final day of the 2024 American Academy of Dermatology Annual Meeting.

Dermatology’s Growth Never Slows Down

Our March 2024 publication features stories that reflect the sense of growth and newness in the specialty.

Celebrating Dermatologists: EltaMD Establishes March 13th as First Annual Observation of National Dermatologist Day

The newly-established observation is a recognition of the commitment of dermatologists to serving the public and aims to bring awareness to the role of dermatology visits, skin checks, and more.

Frontline Forum Part 1: Challenges and Opportunities to Enhance Psoriasis Management

A panel of experts discuss navigating regimen complexity, patient-friendly adherence strategies, addressing steroid phobia and attitudes, and dive into current treatment guidelines.

What Conferences Are You Planning to Attend in Quarter 2 of 2024?

Ahead of the next 3 months of the year, Dermatology Times wants to know what conferences and meetings you plan to attend between April and June. Share your thoughts with us by March 27.

Q&A: Late-Breaking REMIX-1 and REMIX-2 Data Demonstrated Efficacy of Remibrutinib in Chronic Spontaneous Urticaria

Allergist immunologist Giselle Mosnaim, MD, recently spoke with Dermatology Times to discuss late-breaking phase 3 REMIX-1 and REMIX-2 data presented at the American Academy of Allergy, Asthma, and Immunology Annual Meeting.

Recapping Live Coverage, Interviews, and News From the 2024 American Academy of Dermatology Annual Meeting

We've compiled all our coverage from the biggest dermatology meeting of the year to give you a thorough recap of everything you need to know or catch up on.

Considerations for Cardiovascular Risk in Patients With Psoriasis

Patients with psoriatic disease face an increased risk of cardiovascular disease. Clinicians should consider this when determining management and treatment modalities for patients with psoriasis.

Frontline Forum Part 2: Challenges and Opportunities to Enhance Psoriasis Management

A panel of experts discusses unique needs of patients with skin of color, look at long-term safety and efficacy of emerging oral treatments, and delve into combining topicals with systemic therapies.

Phase 2b/3 Trial of Izokibep Meets Primary Endpoints for Psoriatic Arthritis, According to Positive Top-line Results

Acelyrin announced the positive results, of which the primary endpoint was met with high statistical significance, earlier this week.

Addressing the Unique Skin Health Needs of LGBTQ+ Patients

A news release from the American Academy of Dermatology addressed skin-related issues that disproportionately affect LGBTQ+ individuals.

Timeline of Events: Benzene and Carbomer Regulation

Following Valisure’s Citizen’s Petition to the US Food and Drug Administration, we are recapping recent years of regulatory action regarding benzene and carbomers.

Tween Skin Care Mishaps via Misinformation on Social Media

Tween skin care has become a rising trend across social media platforms such as TikTok, and dermatology clinicians are becoming increasingly concerned about misinformation.

Frontline Forum Part 3: Challenges and Opportunities to Enhance Psoriasis Management

A panel of experts discusses tailoring treatment to patient needs, supporting patients' mental health, and considering future directions.

Zoe Diana Draelos, MD, Offers Perspectives on Benzene and Benzoyl Peroxide

With 30 years of clinical dermatology research under her belt, Draelos responds to recent benzene and BPO news in this Q&A.

Journal Digest: March 15

This week’s collection of the latest dermatologic studies covers the relationship between vitamin D receptor expression and cutaneous melanoma outcomes, efficacy of intravenous immunoglobulin in adults with treatment-resistant eosinophilic fasciitis, high dose oral isotretinoin versus low dose for cutaneous and genital warts, and the loss of integrity in the dermal-epidermal junction and hemidesmosomes during skin aging.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.